✦ LIBER ✦

Phase II study of 5-fluorouracil (5-FU) and high dose folinic acid (HDFA) in hepatocellular carcinoma

✍ Scribed by Zaniboni, A; Simoncini, E; Marpicati, P; Marini, G

Book ID: 109836083
Publisher: Nature Publishing Group
Year: 1988
Tongue: English
Weight: 192 KB
Volume: 57
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1988.71

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose folinic acid (HDFA) combined w

High-dose folinic acid (HDFA) combined with 5-fluorouracil (5-FU) in first line chemotherapy of advanced large bowel cancer

✍ Barone, Carlo; Astone, Antonio; Garufi, Carlo; Grieco, Antonio; Cavallaro, Anton 📂 Article 📅 1987 🏛 Elsevier Science ⚖ 358 KB

High dose 5-fluorouracil (5-FU) and foli

High dose 5-fluorouracil (5-FU) and folinic acid in advanced colorectal cancer resistant to standard dose 5-FU treatment: Results of a phase II study

✍ E. Jäger; O. Klein; B. Wächter; B. Müller; U. Braun; A. Knuth 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 136 KB

945 Phase I study of high dose 5-fluorou

945 Phase I study of high dose 5-fluorouracil and folinic acid in weekly continuous infusion

✍ J.M. Limacher; B. Duclos; J. Wihlm; D. Leveque; P. Dufour; F. Eichler; R. Keilin 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Premarin (P) priming before prednimustin

Premarin (P) priming before prednimustine (PDM), high dose folinic acid (HDFA), and 5-fluorouracil (5-FU) as salvage chemotherapy (CT) for advanced breast cancer (ABC). PRELIMINARY results

✍ A. Zaniboni; V. Ferrari; E. Simoncini; P. Marpicati; F. Gorni; G. Marini 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 180 KB

High-dose chronomodulated infusion of 5-

High-dose chronomodulated infusion of 5-fluorouracil (5-FU) and folinic acid (FA) (FF5–16) in advanced colorectal cancer patients

✍ Edmondo Terzoli; Carlo Garufi; Albina Rita Zappalà; Barbara Vanni; Patrizia Pugl 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 217 KB

Randomized phase III Study of 5-fluorour

Randomized phase III Study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced colorectal cancer

✍ Dennie V. Jones; Roger J. Winn; Barry W. Brown; Lawrence B. Levy; Reginald P. Pu 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

Background. Metastatic colorectal cancer is generally incurable. The most active regimen available, 5-fluorouracil(5-FU) and folinic acid (Leucovorin), produces response rates of approximately 25% to 30%. Methyl-lomustine is a nitrosourea with modest activity against colorectal cancer. A randomized